tetano
Editor, Senior Moderator
Cell Cycle
. 2023 Jul 24;1-21.
doi: 10.1080/15384101.2023.2239620. Online ahead of print. COVID-19 of differing severity: from bulk to single-cell expression data analysis
Linlin Tian[SUP] 1 [/SUP], Min He[SUP] 1 [/SUP], Huafeng Fan[SUP] 1 [/SUP], Hongying Zhang[SUP] 1 [/SUP], Xiaoxiao Dong[SUP] 1 [/SUP], Mengkai Qiao[SUP] 1 [/SUP], Chenyu Tang[SUP] 1 [/SUP], Yan Yu[SUP] 1 [/SUP], Tong Chen[SUP] 2 [/SUP], Nan Zhou[SUP] 1 [/SUP]
Affiliations
Coronavirus disease 2019 (COVID-19) is raging worldwide and causes an immense disease burden. Despite this, the biomarkers and targeting drugs of COVID-19 of differing severity remain largely unknown. Based on the GSE164805 dataset, we identified modules most critical for mild COVID-19 (mCOVID-19) and severe COVID-19 (sCOVID-19) through WGCNA, respectively. We subsequently constructed a protein-protein interaction network, and detected 16 hub genes for mCOVID-19 and 10 hub genes for sCOVID-19, followed by the prediction of upstream transcription factors (TFs) and kinases. The enrichment analysis then showed downregulation of TNFA signaling via NFKB for mCOVID-19, as well as downregulation of MYC targets V1 for sCOVID-19. Infiltration degrees of many immune cells, such as macrophages, were also sharply different between mCOVID-19 and sCOVID-19 samples. Predicted protein targeting drugs with the highest scores nearly all belong to naturally derived or synthetic glucocorticoids. For the two single-cell RNA-seq datasets, we explored the expression distribution of hub genes for mCOVID-19/sCOVID-19 in each cell type. The expression levels of PRKCA, MCM5, TYMS, RBBP4, BCL6, FLOT1, KDM6B, and TLR2 were found to be cell-type-specific. Furthermore, the expression levels of 10 hub genes for mCOVID-19 were significantly upregulated in PBMCs between eight healthy controls and eight mCOVID-19 patients at our institution. Collectively, we detected critical modules, pathways, TFs, kinases, immune cells, targeting drugs, hub genes, and their expression distributions in different cell types that may involve the pathogenesis of COVID-19 of differing severity, which may propel earlier diagnosis and more effective treatment of this intractable disease in the future.
. 2023 Jul 24;1-21.
doi: 10.1080/15384101.2023.2239620. Online ahead of print. COVID-19 of differing severity: from bulk to single-cell expression data analysis
Linlin Tian[SUP] 1 [/SUP], Min He[SUP] 1 [/SUP], Huafeng Fan[SUP] 1 [/SUP], Hongying Zhang[SUP] 1 [/SUP], Xiaoxiao Dong[SUP] 1 [/SUP], Mengkai Qiao[SUP] 1 [/SUP], Chenyu Tang[SUP] 1 [/SUP], Yan Yu[SUP] 1 [/SUP], Tong Chen[SUP] 2 [/SUP], Nan Zhou[SUP] 1 [/SUP]
Affiliations
- PMID: 37486005
- DOI: 10.1080/15384101.2023.2239620
Coronavirus disease 2019 (COVID-19) is raging worldwide and causes an immense disease burden. Despite this, the biomarkers and targeting drugs of COVID-19 of differing severity remain largely unknown. Based on the GSE164805 dataset, we identified modules most critical for mild COVID-19 (mCOVID-19) and severe COVID-19 (sCOVID-19) through WGCNA, respectively. We subsequently constructed a protein-protein interaction network, and detected 16 hub genes for mCOVID-19 and 10 hub genes for sCOVID-19, followed by the prediction of upstream transcription factors (TFs) and kinases. The enrichment analysis then showed downregulation of TNFA signaling via NFKB for mCOVID-19, as well as downregulation of MYC targets V1 for sCOVID-19. Infiltration degrees of many immune cells, such as macrophages, were also sharply different between mCOVID-19 and sCOVID-19 samples. Predicted protein targeting drugs with the highest scores nearly all belong to naturally derived or synthetic glucocorticoids. For the two single-cell RNA-seq datasets, we explored the expression distribution of hub genes for mCOVID-19/sCOVID-19 in each cell type. The expression levels of PRKCA, MCM5, TYMS, RBBP4, BCL6, FLOT1, KDM6B, and TLR2 were found to be cell-type-specific. Furthermore, the expression levels of 10 hub genes for mCOVID-19 were significantly upregulated in PBMCs between eight healthy controls and eight mCOVID-19 patients at our institution. Collectively, we detected critical modules, pathways, TFs, kinases, immune cells, targeting drugs, hub genes, and their expression distributions in different cell types that may involve the pathogenesis of COVID-19 of differing severity, which may propel earlier diagnosis and more effective treatment of this intractable disease in the future.